Mativ(US:MATV)2025-08-07 12:30Q2 2025 Financial Performance - Sales increased organically by 2% year-over-year, driven by volume improvements in SAS and favorable currency effects[5, 6] - Adjusted EBITDA increased by 1% compared to the prior year period[5, 6] - Cash from operating activities was $57.6 million, and free cash flow was $48.9 million, up 25% and 33% respectively[6] - GAAP net loss was $9.5 million, with a GAAP EPS of $(0.18)[5, 6] - Adjusted EPS was $0.33, slightly down from $0.34 in the prior year[5] Segment Results - FAM sales decreased by 1% year-over-year, with adjusted EBITDA down by 4%[11] - SAS organic sales increased by 5% year-over-year, but adjusted EBITDA decreased by 2%[11, 12] Forward Outlook and Strategic Initiatives - Expect Q3 adjusted EBITDA to increase 5-10% year-over-year, with favorable cash flow generation[6] - Target $15 million - $20 million in additional cost reductions in 2025[14] - Target $40 million in capital expenditures for 2025, a reduction from $55 million in 2024[14] - Target $20 million - $30 million in inventory reduction by year-end 2025[14]